Arcutis Biotherapeutics Share Price Today
(NASDAQ: ARQT)

Name: Arcutis Biotherapeutics Share Price Today (NASDAQ: ARQT) - Arcutis Biotherapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Arcutis Biotherapeutics share price is $14.78 & ₹1,285.40 as on 6 Mar 2025, 2.30 'hrs' IST

$14.78

▲

1.38

(10.3%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Arcutis Biotherapeutics share price in Dollar and Rupees. Guide to invest in Arcutis Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Arcutis Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Arcutis Biotherapeutics share price movements

Today's Low: $13.57
Today's High: $14.81
$14.78
8.22%
Downside
Day's Volatility :8.38%
Upside
0.17%
52 Weeks Low: $6.99
52 Weeks High: $16.20
$14.78
52.71%
Downside
52 Weeks Volatility :56.85%
Upside
8.77%

Arcutis Biotherapeutics (ARQT) Returns

Period	Arcutis Biotherapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	8.85%	2.1%	0.0%
6 Months	23.73%	-4.1%	0.0%
1 Year	28.35%	2.2%	0.0%
3 Years	-18.84%	11.8%	-11.6%

Arcutis Biotherapeutics (ARQT) Key Statistics

in dollars & INR

Previous Close	$13.4
Open	$13.35
Today's High	$14.805
Today's Low	$13.565
Market Capitalization	$1.5B
Today's Volume	$1.0M
52 Week High	$16.2
52 Week Low	$6.99
Revenue TTM	$196.5M
EBITDA	$-125.8M
Earnings Per Share (EPS)	$-1.16
Profit Margin	-71.25%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-113.76%

How to invest in Arcutis Biotherapeutics Stock (ARQT) from India?

It is very easy for Indian residents to invest directly in Arcutis Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arcutis Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arcutis Biotherapeutics or ARQT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arcutis Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arcutis Biotherapeutics shares which would translate to 0.059 fractional shares of Arcutis Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Arcutis Biotherapeutics, in just a few clicks!

Returns in Arcutis Biotherapeutics (ARQT) for Indian investors in Rupees

The Arcutis Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Arcutis Biotherapeutics investment value today

Current value as on today

₹1,46,534

Returns

₹46,534

(+46.53%)

Returns from Arcutis Biotherapeutics Stock

₹41,571 (+41.57%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Arcutis Biotherapeutics (ARQT)

77%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Arcutis Biotherapeutics Stock from India on INDmoney has increased by 77% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Arcutis Biotherapeutics

Jennison Associates LLC
10.40%
Suvretta Capital Management, LLC
9.61%
Rubric Capital Management LP
9.24%
BlackRock Inc
7.71%
Polar Capital Holdings PLC
6.22%
Vanguard Group Inc
5.43%

Analyst Recommendation on Arcutis Biotherapeutics

Buy

76%Buy

23%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Arcutis Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Arcutis Biotherapeutics Stock (ARQT)

What analysts predicted

Upside of 34.47%

Target:

$19.88

Current:

$14.78

Insights on Arcutis Biotherapeutics Stock (Ticker Symbol: ARQT)

Price Movement
In the last 7 days, ARQT stock has moved up by 1.4%
Increasing Revenue
Revenue is up for the last 3 quarters, 30.85M → 71.36M (in $), with an average increase of 34.2% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -52.33M → -10.78M (in $), with an average increase of 155.5% per quarter
ARQT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 39.4%
ARQT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 67.9%
Price to Sales
ForARQT every $1 of sales, investors are willing to pay $8.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Arcutis Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Arcutis Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Arcutis Biotherapeutics (ARQT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Arcutis Biotherapeutics Inc	2.29%	23.73%	28.35%	-18.84%	-52.75%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Arcutis Biotherapeutics Inc	NA	NA	NA	-0.6	-1.14	-0.23	NA	1.34
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Arcutis Biotherapeutics Inc	Buy	$1.5B	-52.75%	NA	-71.25%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It is also developing ARQ-154, a topical ZORYVE foam for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a JAK1-selective topical cream in development for hand eczema and vitiligo; ARQ-255, a selective small molecule inhibitor of JAK1 for the treatment of alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Organization	Arcutis Biotherapeutics
Employees	342
CEO	Mr. Todd Franklin Watanabe M.A.
Industry	Health Technology

Management People of Arcutis Biotherapeutics

Name	Title
Mr. Todd Franklin Watanabe M.A.	President, CEO & Director
Dr. Bhaskar Chaudhuri Ph.D.	Co-Founder & Independent Director
Dr. Patrick E. Burnett M.D., Ph.D.	Executive VP & Chief Medical Officer
Mr. L. Todd Edwards	Executive VP & Chief Commercial Officer
Mr. David J. Topper	Senior VP & Chief Financial Officer
Mr. Rajvir Madan	Chief Digital & Technology Officer
Ms. Courtney Barton	VP and Chief Compliance Officer & Privacy Officer
Mr. Masaru Matsuda Esq., J.D.	Senior VP, General Counsel & Corporate Secretary
Ms. Amanda Sheldon	Head of Corporate Communications
Mr. Kent Taylor	Senior Vice President of Sales

Important FAQs about investing in ARQT Stock from India :

What is Arcutis Biotherapeutics share price today?

Arcutis Biotherapeutics share price today stands at $14.78, Open: $13.35 ; Previous Close: $13.40 ; High: $14.81 ; Low: $13.57 ; 52 Week High: $16.20 ; 52 Week Low: $6.99.

The stock opens at $13.35, after a previous close of $13.40. The stock reached a daily high of $14.81 and a low of $13.57, with a 52-week high of $16.20 and a 52-week low of $6.99.

Can Indians buy Arcutis Biotherapeutics shares?

Yes, Indians can invest in the Arcutis Biotherapeutics (ARQT) from India.

With INDmoney, you can buy Arcutis Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Arcutis Biotherapeutics at zero transaction cost.

How can I buy Arcutis Biotherapeutics shares from India?

It is very easy to buy Arcutis Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arcutis Biotherapeutics (ARQT) be purchased?

Yes, you can buy fractional shares of Arcutis Biotherapeutics with INDmoney app.

What are the documents required to start investing in Arcutis Biotherapeutics stocks?

To start investing in Arcutis Biotherapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.